Loading
As the World is fighting against COVID -19, everyone is eagerly waiting to know more about the preventive vaccine and its availability to the public. In these unprecedented circumstances, the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences is organizing a series of webinars to cover topics related to COVID-19. Our panel of Award winners will share their experience with you and discuss future medical practice in light of the situation.
This webinar will present Professor Stanley Plotkin, Emeritus Professor at the University of Pennsylvania, and Adjunct Professor at Johns Hopkins University, as well as Professor of Virology at the Wistar Institute. He’ll speak on the topic “vaccine for difficult target'. For seven years he was the Medical and Scientific Director at Pasteur-Merieux-Connaught (now known as Sanofi Pasteur). Stanley Plotkin has made an outstanding and exceptional impact on the field. He not only developed the rubella vaccine, which saved millions of children from congenital abnormalities, but has contributed to the development of a pentavalent rotavirus vaccine, an anthrax vaccine, the oral poliovirus vaccine, the cultured rabies vaccine and a varicella vaccine. Professor Plotkin was the winner of the Hamdan Award for Medical Research Excellence – Vaccines in 2014.
He will be joined by Dr. Harriet Robinson, Emeritus Professor of Microbiology and Immunology at Emory University School of Medicine, who will speak on the “prospects of the SARS- COV- 2 vaccine”. Dr. Robinson has a multi-protein clade B DNA/MVA vaccine regimen in clinical trials through the US HIV vaccine Trials Network (HVTN). The vaccine was developed in Dr. Robinson's former laboratory at the Emory Vaccine Center in collaboration with Dr. Bernard Moss's laboratory at the US NIH. In addition, Dr. Robinson is the Scientific Founder of GeoVax Labs, Inc., a clinical-stage vaccine and cancer immunotherapy company, where she is Chief Scientific Officer Emeritus and continues to serve on the GeoVax Board of Directors. She is the developer of GeoVax's HIV/AIDS vaccine technology and is one of the world's leaders in HIV/AIDS vaccine research.
The session will be moderated by Professor Sehamuddin Galadari, the chairman of Medical research grant committee in the Award, Senior Vice Provost of Research; Managing Director, Research Institute; Professor of Biology- NYU- Abu Dhabi.
Professor Stanley Plotkin, Emeritus Professor of the University of Pennsylvania, and Adjunct Professor of the Johns Hopkins University, as well as Professor of Virology at the Wistar Institute.
He not only developed the rubella vaccine, but has contributed to the development of a pentavalent rotavirus vaccine, the oral poliovirus vaccine among others. Professor Plotkin was the winner of the Hamdan Award for Medical Research Excellence – Vaccines in 2014.
Professor Harriet Robinson, Emeritus Professor of Microbiology and Immunology at Emory University School of Medicine.
She is the developer of GeoVax's HIV/AIDS vaccine technology and is one of the world's leaders in HIV/AIDS vaccine research.
Dr. Alfadhel is currently Deputy Executive of King Abdullah International Medical Research Centre (KAIMRC). The Head of Genetics Division, Department of Pediatrics at King Abdulaziz Medical City, Riyadh, Saudi Arabia and associate professor at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS). He is the director of medical genomic research laboratory. Furthermore, he is the Editor in chief of journal of Biochemical and Clinical Genetics and editorial board member of International Journal of Health Sciences and editorial board member of the Journal of Nature and Science of Medicine (JNSM).
He is also a Chair at the Newborn Screening Program at NGHA, member of credential committee board at Canadian College of Medical Geneticists (CCMG), member of Middle East Hyperammonemia and UCDs Scientific Group (MHUSG), member of and several international advisory boards, groups and committee. Dr. Alfadhel’s foresight and passion for innovation, earned him an award for inventing a new application in the Apple store and Google play for the treatment of inborn errors of metabolism. He has published more than 100 research papers in the field of Genetics disorders, Dr. Alfadhel’s current research interest is focused on studying genetic disorders related to inborn errors of metabolism and he contribute to discovery of >50 genes in the field of Genetic disorders.
Dr. Alfadhel received his bachelor degree in general medicine and surgery from King Saud University in Riyadh. He obtained his pediatric residency from King Abdulaziz Medical City in Riyadh and received the Pediatric Saudi Board certificate followed by Pediatric Arab Board certificate and the Canadian Board in Biochemical Genetics. In addition, he carries a Neurogenetics fellowship certificate and Master of Health Science (MHSc) in epidemiology.
